Ever read something in your inbox that made you stop mid-scroll? That’s how we felt reading a recent update from PharMerica about new COVID-19 vaccine guidance for immunocompromised residents. These updates aren’t just another tweak to protocol. They remind us how vital it is to stay current when caring for those who need more protection.

The Infectious Diseases Society of America (IDSA) now recommends a bivalent COVID-19 mRNA vaccine as the primary series for adults with moderate to severe immune compromise. Additional boosters may follow, depending on each resident’s health needs. This is part of a larger plan that also includes RSV and flu prevention. You’ll find more in IDSA’s seasonal vaccination guidance for immunocompromised patients.

What makes this update helpful is the flexibility it offers. As noted by CIDRAP, providers are encouraged to consider treatment timing and illness severity before making vaccine decisions. That kind of personalization helps your staff give the right care to residents on chemotherapy or those managing chronic conditions.

Communication plays a key role too. VaxIntegrity, a CIDRAP resource, stresses the power of consistent vaccine messaging. When families understand why boosters are needed, trust increases. It also helps reduce confusion or hesitancy when new doses are recommended.

So what’s next? Talk with your Medical Director. Review your vaccine protocols and make sure staff know how to apply the latest guidance. These residents count on you not just for the vaccines, but for confidence in the care they receive.

Stay well and stay informed!